Yaupon Therapeutics Inc. Appoints New Management Team  
7/18/2011 9:43:34 AM

MALVERN, Pa.--(BUSINESS WIRE)--Yaupon Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today the appointment of nine new management team members. The new management team will strengthen the company’s foundation and drive momentum as it prepares the NDA submission for its propriety gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL).